For laboratory research use only (in vitro). Not for human or animal use.
| Quantity | Discount | Unit Price |
|---|---|---|
| 1-2 units | Standard | $47.99 |
| 3-4 units | 5% off | $45.59 |
| 5-9 units | 10% off | $43.19 |
| 10+ units Best Value | 15% off | $40.79 |
Why researchers choose PBC:
Accepted payment methods:
Certificate of Analysis available upon request. Contact us for lot-specific documentation.
| Amino Acid Sequence | His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 |
|---|---|
| Molecular Weight | 887 Da |
| Molecular Formula | C47H58N12O6 |
| CAS Number | 140703-51-1 |
| Purity | ≥98% (HPLC) |
| Format | Lyophilized Powder |
| Vials Per Kit | 10 |
| Storage | Store at -20C. Reconstituted: 2-8C |
| Research Status | Phase2 |
For laboratory research use only (in vitro). Not for human or animal use.
Hexarelin analytical reference compound. Molecular weight 887 Da.
| Sequence | His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2 |
| Molecular Weight | 887 Da |
| Molecular Formula | C47H58N12O6 |
| CAS | 140703-51-1 |
| Purity | >=98% (HPLC) |
| Format | Lyophilized powder |
| Storage | Store at -20C. Reconstituted: 2-8C |
For laboratory research use only (in vitro). Not for human or animal use.
| Size | 2mg, 5mg |
|---|
4 references
References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man
Ghigo E, Arvat E, Muccioli G, et al. (1994). Journal of Clinical Endocrinology and Metabolism. PubMed 8126144
Cardiac effects of hexarelin in hypopituitary adults with GH deficiency
Broglio F, Benso A, Valetto MR, et al. (2000). European Journal of Pharmacology
Hexarelin protects the heart from acute myocardial ischemia-reperfusion injury through CD36 scavenger receptor
Bhatt N, Bhatt P, et al. (2005). American Journal of Physiology – Heart and Circulatory Physiology
Desensitization of the GH response to hexarelin during chronic administration in adults with GH deficiency
Arvat E, Di Vito L, Broglio F, et al. (1997). Journal of Clinical Endocrinology and Metabolism. PubMed 9589671
For laboratory research use only (in vitro). Not for human or animal use.